Reagents The following antibodies and their corresponding Research Resource Identifiers (RRIDs) were used in this study: SLC25A39 (RRID: AB_2878095, AB_2605624), SLC25A40 (RRID: AB_1310678), AFG3L2 (RRID: AB_2637746, AB_1209606), HSP60 (RRID: AB_881444), -actin (RRID: AB_10950489), GAPDH (RRID: AB_307272), cleaved caspase-3 (RRID: AB_302962), cleaved caspase-9 (RRID: AB_2889070), cleaved PARP (RRID: AB_777102), HEY1 (RRID: AB_2576326), pro-caspase-3 (RRID: AB_2069711), pro-caspase-9 (RRID: AB_2809709), HES1 (RRID: AB_2546278), and NOTCH1 (RRID: AB_467579)
Wegovy (Semaglutide for Weight Loss) Wegovy uses the same active compound as Ozempic but at higher doses (up to 2.4 mg weekly) and is specifically indicated for chronic weight management in adults with obesity or overweight plus a comorbidity
While some weight regain can happen if lifestyle changes arent maintained, the goal of our program is to help you build sustainable habits
Do not use while pregnant or nursing without medical guidance